Exane Derivatives’s ArcelorMittal MT Stock Holding History

Exane Derivatives’s Portfolio MT Stock Details MT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,000	Closed	-$523K	–	647
2017 Q4	$523K	Buy	+2,000	New	+$59.2K	0.09%	158

Other funds holding MT

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Exane Derivatives's MT Position: Q1 2019 in Review

Exane Derivatives sold out of ArcelorMittal (MT) in Q1 2019, closing a stake of 102,858 shares — an estimated $2.13M sold.

Exane Derivatives first reported a position in MT in Q4 2014 and held it in 15 quarters. The position peaked at $8.82M in Q3 2018. 174 funds tracked by Wall St. Rank hold MT as of Q1 2019.

Exane Derivatives reported no remaining ArcelorMittal position as of Q1 2019 after selling out during the quarter.
Exane Derivatives sold 102,858 ArcelorMittal shares in Q1 2019, an estimated $2.13M.
Exane Derivatives first reported a position in ArcelorMittal in Q4 2014 and held it in 15 quarters.
Exane Derivatives's ArcelorMittal position peaked at $8.82M in Q3 2018.
174 funds tracked by Wall St. Rank held ArcelorMittal as of Q1 2019.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.